Genfit.fr

Categories: New newsletter subcribe

130Newsletters

0Subscriptions

Click here to subscribe to Genfit.fr

Newsletters

GENFIT : Information financire du troisime trimestre 2016 -- Third quarter 2016 financial information Genfit.fr
8 years ago
GENFIT annonce ladmission de deux nouveaux abstracts dont lun sera prsent en session orale lors du congrs de lAASLD 2016 -- GENFIT announces the acceptance of two new abstracts, including one to be presented in an oral session at the 2016 AASLD meeting Genfit.fr
8 years ago
GENFIT : Nouvelles donnes prsentes lors du prochain congrs annuel de lAASLD ; forte implication dans la confrence inaugurale NASH-TAG -- GENFIT: New Scientific Data to be Presented During Next AASLD Annual Meeting; Strong Involvement in the First-Ever NASH-TAG Conference Genfit.fr
8 years ago
GENFIT initie sa demande dIND pour elafibranor dans la nouvelle indication Cholangite Biliaire Primitive (CBP) -- GENFIT is Filing for IND Submission for New Indication of Elafibranor in Primary Biliary Cholangitis (PBC) Genfit.fr
8 years ago
GENFIT : Rsultats du 1er semestre 2016 : Trsorerie de fin de priode de 94 M et avances majeures dans le cadre du programme Elafibranor -- H1 2016 Results: Cash position at end of period at 94M and significant advances in Elafibranor program Genfit.fr
8 years ago
GENFIT : Lancement dun programme clinique dans la Cirrhose Biliaire Primitive (CBP) - GENFIT to Begin Elafibranor Clinical Program in PBC Genfit.fr
8 years ago
GENFIT : Les prsentations pour EASL/ILC 2016 soulignent les avances en matire de traitement de la NASH, de biomarqueurs diagnostiques, et de programmes anti-fibrose -- GENFIT: Presentations at EASL/ILC 2016 Highlight Progress in NASH Treatment, Biomarker Diagnostics, and Programs Targeting Fibrotic Diseases Genfit.fr
8 years ago
GENFIT : Organisation d'un vnement R&D le 31 Mars 2016 - GENFIT to Host R&D Event on March 31, 2016 Genfit.fr
8 years ago
GENFIT : Inclusion du premier patient dans ltude clinique RESOLVE-IT, Phase 3 dElafibranor dans la NASH - GENFIT announces enrollment of first patient in RESOLVE-IT, the pivotal Phase 3 clinical trial of Elafibranor in NASH Genfit.fr
8 years ago
Meilleurs Voeux 2016 ! Holiday Greetings from GENFIT Genfit.fr
9 years ago

© 2024